Search company, investor...



Other Investors | Alive

About SBIO Pte

SBIO is focused on the discovery and development of small molecule oncology drugs.

Headquarters Location

Redwood City, California, 94061,

United States

Missing: SBIO Pte's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SBIO Pte's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing SBIO Pte

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SBIO Pte is included in 1 Expert Collection, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

SBIO Pte Frequently Asked Questions (FAQ)

  • Where is SBIO Pte's headquarters?

    SBIO Pte's headquarters is located at Redwood City.

  • What is SBIO Pte's latest funding round?

    SBIO Pte's latest funding round is Other Investors.

  • Who are the investors of SBIO Pte?

    Investors of SBIO Pte include Novartis Venture Funds.

  • Who are SBIO Pte's competitors?

    Competitors of SBIO Pte include Evotec SE, Evolva Holding, Kiadis Pharma, Akebia Therapeutics, Relypsa and 13 more.

Compare SBIO Pte to Competitors

Endotis Pharma

Endotis Pharma is A specialty discovery and development company developing small glycol drugs for thrombosis and oncology


Palkion, Inc. is a private early stage company developing oral drugs to treat anemia based on the discovery and development of compounds that inhibit prolyl hydroxylase enzymes.


OyaGen is a biotechnology company discovering, developing, and commercializing pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. The company will pursue several assays in high throughput screening strategies for drug development. OyaGen seeks to bring to market the anti-HIV drugs targeting Vif and APOBEC3G that solve the problems of viral resistance, a major shortcoming of all current therapies. In the long run, the Company will draw on its core expertise in Editing Enzyme technologies to develop therapies for other disease states.

Calyx Therapeutics

Calyx Therapeutics is a pharmaceutical company focusing on oral therapies for diabetes and inflammatory diseases. Calyx utilizes natural plant extracts with demonstrated clinical activity in humans as the source of its discovery efforts. The company isolates the biologically active molecule, determines its chemical structure, and aims to develop small molecule analogs. This process aims to reduce the time and investment required to take lead molecules into preclinical and clinical testing.


Oxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.

Tequesta Marine Biosciences

Tequesta Marine Biosciences is a specialty pharmaceutical firm that develops small molecule therepeutic drugs for inflammatory conditions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.